ReviewDrugs2022
Tezepelumab: First Approval.
Sheridan M HoyPubMed ↗Publisher ↗
No numbers read from the abstract.
61 papers cite itlatest 60 shown
this papertrialcites it
ReviewDrugs2022
Sheridan M HoyPubMed ↗Publisher ↗
No numbers read from the abstract.